123 related articles for article (PubMed ID: 7557882)
1. Introduction of a murine p53 mutation corresponding to human codon 249 into a murine hepatocyte cell line results in growth advantage, but not in transformation.
Dumenco L; Oguey D; Wu J; Messier N; Fausto N
Hepatology; 1995 Oct; 22(4 Pt 1):1279-88. PubMed ID: 7557882
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
Oguey D; Dumenco LL; Pierce RH; Fausto N
Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a murine p53ser246 mutant equivalent to the human p53ser249 associated with hepatocellular carcinoma and aflatoxin exposure.
Ghebranious N; Knoll BJ; Wu H; Lozano G; Sell S
Mol Carcinog; 1995 Jun; 13(2):104-11. PubMed ID: 7605578
[TBL] [Abstract][Full Text] [Related]
4. The human p53 gene mutated at position 249 per se is not sufficient to immortalize human liver cells.
Schleger C; Becker R; Oesch F; Steinberg P
Hepatology; 1999 Mar; 29(3):834-8. PubMed ID: 10051487
[TBL] [Abstract][Full Text] [Related]
5. Control of mouse hepatocyte proliferation and ploidy by p53 and p53ser246 mutation in vivo.
Yin L; Ghebranious N; Chakraborty S; Sheehan CE; Ilic Z; Sell S
Hepatology; 1998 Jan; 27(1):73-80. PubMed ID: 9425920
[TBL] [Abstract][Full Text] [Related]
6. The mouse equivalent of the human p53ser249 mutation p53ser246 enhances aflatoxin hepatocarcinogenesis in hepatitis B surface antigen transgenic and p53 heterozygous null mice.
Ghebranious N; Sell S
Hepatology; 1998 Apr; 27(4):967-73. PubMed ID: 9537435
[TBL] [Abstract][Full Text] [Related]
7. Transfected mutant p53 gene increases X-ray-induced cell killing and mutation in human fibroblasts immortalized with 4-nitroquinoline 1-oxide but does not induce neoplastic transformation of the cells.
Kawashima K; Mihara K; Usuki H; Shimizu N; Namba M
Int J Cancer; 1995 Mar; 61(1):76-9. PubMed ID: 7705936
[TBL] [Abstract][Full Text] [Related]
8. Mutations associated with in vivo aflatoxin B1-induced carcinogenesis need not be present in the in vitro transformations by this toxin.
Stanley LA; Mandel HG; Riley J; Sinha S; Higginson FM; Judah DJ; Neal GE
Cancer Lett; 1999 Apr; 137(2):173-81. PubMed ID: 10374839
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of a mouse liver epithelial cell line by transfection of an activated c-H-ras gene with a point mutation at codon 12.
Kanda H; Lee GH; Nomura K; Ohtake K; Kitagawa T
Carcinogenesis; 1993 May; 14(5):1061-3. PubMed ID: 8504467
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain.
Challen C; Lunec J; Warren W; Collier J; Bassendine MF
Hepatology; 1992 Dec; 16(6):1362-6. PubMed ID: 1332921
[TBL] [Abstract][Full Text] [Related]
12. Cooperation of p53 loss of function and v-Ha-ras in transformation of mouse keratinocyte cell lines.
Azzoli CG; Sagar M; Wu A; Lowry D; Hennings H; Morgan DL; Weinberg WC
Mol Carcinog; 1998 Jan; 21(1):50-61. PubMed ID: 9473771
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
14. p53Val135 temperature sensitive mutant suppresses growth of human breast cancer cells.
Eliyahu D; Evans S; Rosen N; Eliyahu S; Zwiebel J; Paik S; Lippman M
Breast Cancer Res Treat; 1994; 30(2):167-77. PubMed ID: 7949216
[TBL] [Abstract][Full Text] [Related]
15. Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein.
Cajot JF; Anderson MJ; Lehman TA; Shapiro H; Briggs AA; Stanbridge EJ
Cancer Res; 1992 Dec; 52(24):6956-60. PubMed ID: 1458487
[TBL] [Abstract][Full Text] [Related]
16. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines.
Macé K; Aguilar F; Wang JS; Vautravers P; Gómez-Lechón M; Gonzalez FJ; Groopman J; Harris CC; Pfeifer AM
Carcinogenesis; 1997 Jul; 18(7):1291-7. PubMed ID: 9230270
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization in vivo of mutant p53 molecules derived from squamous cell carcinomas of the head and neck.
Cardinali M; Kratochvil FJ; Ensley JF; Robbins KC; Yeudall WA
Mol Carcinog; 1997 Feb; 18(2):78-88. PubMed ID: 9049183
[TBL] [Abstract][Full Text] [Related]
18. The p53 codon 249 mutant--derived from human functional adrenal tumors--can modify the cell shape of normal adrenocortical transfected cells.
Hsu CH; Lee SC; Yang YC; Lian ST; Shin SJ; Lin SR
Cancer Lett; 2001 Sep; 170(1):63-71. PubMed ID: 11448536
[TBL] [Abstract][Full Text] [Related]
19. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
Wang H; Lai B; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
[TBL] [Abstract][Full Text] [Related]
20. Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma.
Sun Y; Nakamura K; Wendel E; Colburn N
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2827-31. PubMed ID: 8464896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
